HomeInsightsStock Comparison

Fdc Ltd vs Ind Swift Laboratories Ltd Stock Comparison

Fdc Ltd vs Ind Swift Laboratories Ltd Stock Comparison

Last Updated on: Jun 18, 2025

Key Highlights

  • The Latest Trading Price of FDC Ltd is ₹ 472.65 as of 18 Jun 10:33.
  • The P/E Ratio of FDC Ltd changed from 14 on March 2020 to 22.6 on March 2024 . This represents a CAGR of 10.05% over 5 yearsThe P/E Ratio of Ind-Swift Laboratories Ltd changed from 6.9 on March 2023 to 1.4 on March 2024 . This represents a CAGR of -54.96% over 2 years.
  • The Market Cap of FDC Ltd changed from ₹ 3350 crore on March 2020 to ₹ 6912 crore on March 2024 . This represents a CAGR of 15.59% over 5 yearsThe Market Cap of Ind-Swift Laboratories Ltd changed from ₹ 128.22 crore on March 2020 to ₹ 580.82 crore on March 2024 . This represents a CAGR of 35.27% over 5 years.
  • The revenue of FDC Ltd for the Mar '25 is ₹ 507.97 crore as compare to the Dec '24 revenue of ₹ 482.94 crore. This represent the growth of 5.18% The revenue of Ind-Swift Laboratories Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 22.48 crore. This represent the decline of -100%.
  • The ebitda of FDC Ltd for the Mar '25 is ₹ 70.06 crore as compare to the Dec '24 ebitda of ₹ 65.48 crore. This represent the growth of 6.99% The ebitda of Ind-Swift Laboratories Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ -0.72 crore. This represent the decline of -100%.
  • The net profit of FDC Ltd changed from ₹ 109.81 crore to ₹ 38.67 crore over 8 quarters. This represents a CAGR of -40.66% The net profit of Ind-Swift Laboratories Ltd changed from ₹ 17.4 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% .
  • The Dividend Payout of FDC Ltd changed from 5.54 % on March 2020 to 0 % on March 2024 . This represents a CAGR of -100.00% over 5 yearsThe Dividend Payout of Ind-Swift Laboratories Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About FDC Ltd

  • FDC Limited is a fully integrated, research-oriented pharmaceutical company engaged in the manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs).
  • The Company is a prominent player in the Indian pharmaceutical industry, renowned for its expertise in developing specialised formulations.
  • It leads the market in sectors such as Oral Rehydration Solutions (ORS), energy drinks, antibiotics and ophthalmic therapies.
  • It has established a global footprint in both domestic and international market, standing as a beacon of excellence in pharmaceutical and consumer healthcare industry. Promoted as a partnership firm in 1936 by the Late Anand Chandravarkar to import pharmaceutical dosage forms, specialised infant foods and surgical goods, FDC Limited was established on September 23, 1940.

About Ind-Swift Laboratories Ltd

  • Ind-Swift Laboratories Limited is a part of the Ind-Swift Group and is based at Chandigarh, India.
  • The Company is one of the leading manufacturers of APIs catering to global and domestic formulators.
  • Based in Chandigarh, India, the Company operated two advanced manufacturing facilities in Derabassi and Jammu, adhering to international standards.
  • Ind-Swift Laboratories Ltd. is recognised globally as a leader in the Macrolide Antibiotic sector, and its products are well-regarded by major pharmaceutical formulators worldwide. Ind-Swift Laboratories Limited was incorporated on January 4, 1995 as a joint venture between Ind-Swift Ltd and Punjab State Industrial Development Corporation.
  • Later, Ind-Swift purchased Punjab State Industrial Development Corporation equity to emerge as a single largest shareholder in the company.

FDC Ltd News Hub

News

Volumes jump at FDC Ltd counter

Bajaj Finance Ltd, P I Industries Ltd, Anand Rathi Wealth Ltd, Cipla Ltd are among the oth...

Read more

16 Jun 2025 11:00

News

FDC to conduct board meeting

FDC will hold a meeting of the Board of Directors of the Company on 28 May 2025. Powered b...

Read more

23 May 2025 17:29

News

FDC to declare Quarterly Results

FDC will hold a meeting of the Board of Directors of the Company on 12 February 2025. Powe...

Read more

08 Feb 2025 11:03

News

FDC gets USFDA nod for anti-bacterial drug

The announcement was made at the fag end of market hours yesterday. Cefixime is used to tr...

Read more

19 Dec 2024 10:47

News

Board of FDC recommends first interim dividend

FDC announced that the Board of Directors of the Company at its meeting held on 6 November...

Read more

07 Nov 2024 15:15

News

FDC schedules board meeting

FDC will hold a meeting of the Board of Directors of the Company on 6 November 2024 Powere...

Read more

29 Oct 2024 15:20

Ind-Swift Laboratories Ltd News Hub

News

Ind-Swift Laboratories schedules board meeting

Ind-Swift Laboratories will hold a meeting of the Board of Directors of the Company on 30 ...

Read more

24 May 2025 18:25

News

Ind-Swift Laboratories adjourns board meeting

Ind-Swift Laboratories has adjourned the meeting of the Board of Directors which was sched...

Read more

14 Feb 2025 11:01

News

Ind-Swift Laboratories announces cessation of director

Ind-Swift Laboratories announced the cessation of Dr. Ashwani Kumar Vig as Independent Dir...

Read more

13 Feb 2025 19:26

News

Ind-Swift Laboratories adjourns board meeting

Ind-Swift Laboratories has adjourned the meeting of the Board of Directors which was sched...

Read more

13 Feb 2025 11:33

News

Ind-Swift Laboratories to announce Quarterly Result

Ind-Swift Laboratories will hold a meeting of the Board of Directors of the Company on 12 ...

Read more

07 Feb 2025 16:48

News

Ind-Swift Laboratories to hold EGM

Ind-Swift Laboratories announced that an Extra Ordinary General Meeting (EGM) of the Compa...

Read more

21 Jan 2025 14:05

SWOT Analysis Of FDC Ltd

Strength

3

S

Weakness

3

W

Opportunity

0

O

Threats

2

T

SWOT Analysis Of Ind-Swift Laboratories Ltd

Strength

5

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

BlinkX Score for FDC Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Ind-Swift Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of FDC Ltd and Ind-Swift Laboratories Ltd

Which company has a larger market capitalization, FDC Ltd or Ind-Swift Laboratories Ltd?

Market cap of FDC Ltd is 7,703 Cr while Market cap of Ind-Swift Laboratories Ltd is 622 Cr

What are the key factors driving the stock performance of FDC Ltd and Ind-Swift Laboratories Ltd?

The stock performance of FDC Ltd and Ind-Swift Laboratories Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for FDC Ltd and Ind-Swift Laboratories Ltd?

As of June 18, 2025, the FDC Ltd stock price is INR ₹473.15. On the other hand, Ind-Swift Laboratories Ltd stock price is INR ₹102.61.

How do dividend payouts of FDC Ltd and Ind-Swift Laboratories Ltd compare?

To compare the dividend payouts of FDC Ltd and Ind-Swift Laboratories Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions